KNSA (KNSA) Stock Price & Analysis
KNSA (KNSA) fell 3.18% to USD 77.91 as of September 8, 2026 at 04:59 UTC, according to Nexqual real-time market data.
KNSA last closed at USD 77.91; the session ranged USD 77.9–80.43 on volume of 430,045 shares. Market capitalization is —, with a 52-week range of USD 35.2–82.94 (NMS). Source: Nexqual, September 8, 2026 at 04:59 UTC.
Key Statistics (as of September 8, 2026 at 04:59 UTC)
| Price | USD 77.91 |
|---|---|
| Change | ▼ 3.18% (down) |
| Previous Close | USD 77.91 |
| Open | USD 77.91 |
| Day Range | USD 77.9 – 80.43 |
| 52-Week Range | USD 35.2 – 82.94 |
| Volume | 430,045 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KNSA)
Nexqual's technical model rates KNSA "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:59 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 56.45 (neutral) |
| vs SMA50 | Above (USD 71.87) |
| MACD | 2.07 (positive) |
From KNSA's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | USD 358.24 | ▼ 2.98% |
| MIRM | Mirum Pharmaceuticals, Inc. | USD 100.9 | ▲ 1.07% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 102.74 | ▼ 2.54% |
| SRRK | Scholar Rock Holding Corporatio | USD 55.33 | ▼ 1.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:59 UTC. This page is informational and not investment advice.